Company name
2022Founder
Timothy Ingallinera leads drug product development at Scribe Therapeutics, following formulation and pharmaceutical-sciences leadership at Nurix and Acerta. His work connects formulation, analytical development and manufacturing with the cross-functional decisions needed to move research into clinical development.
Director, Drug Product Development
Associate Director, Formulations
Associate Director of Pharmaceutical Sciences
Research Chemist
Research Associate
Research Associate
Research Associate
Research Assistant
Research Assistant
Support Assistant
Bachelor's studies in chemistry